Chika Ogami, Mikiko Nakamura, Christina Friedrich, Robert Sheehan, Rebecca Baillie, Katherine Kudrycki, Jared Cui, Michael Weis, Sumire Shimada, Kimio Terao, Ryoko Takubo

Quantitative systems pharmacology modelling for evaluating the impact of interleukin 6 on the development and progression of sepsis induced acute respiratory distress syndrome

Presented by Chugai Pharmaceutical Co and Rosa at ACoP14, 2023

Conference Presentation

Christina Friedrich

QSP Modelers – Take Your Data Seriously, Not Literally!

Presented by Rosa at ACoP14, 2023


Krishnakant Dasika, Renee Myers, Colleen Witt, Christina Friedrich

Pathway-Driven Parameter Sampling Improves Quality and Efficiency of QSP Virtual Patient Generation

Presented by Rosa at ACoP14, 2023

White Paper

William C. Brastow, PhD

Combining Qualitative and Quantitative Market Research in Life Science Product Commercialization

White Paper

Dr. Bill Brastow

Commercializing Life Science Products

White Paper

Bill Brastow, PhD

Discrete Choice Modeling for Diagnostic Tests

White Paper

Bill Brastow

Discrete Choice Modeling for Prescription Therapies

Oral Presentation

Vincent Hurez

Personalized Medicine: Perspectives for Multifaceted Autoimmune Diseases

ISoP Virtual Quantitative Systems Pharmacology Week 2023

Peer Reviewed Journal Publication

Renée C. Myers, Florian Augustin, Jérémy Huard, Christina M. Friedrich

Using machine learning surrogate modeling for faster QSP VP cohort generation

Published in CPT Pharmacometrics Systems Pharmacology, Online ahead of print.


Vincent Hurez, Alvaro Ruiz-Martinez, Lesley Benyon, Krishnakant Dasika, Mike Reed, Glenn Gauderat, Audrey Aussy, Laurence Laigle, Sylvie Bretin, Sylvain Fouliard, Emiko Desvaux, Perrine Soret, Joël A G van Roon, Philippe Moingeon

Development of a primary Sjogren’s Syndrome (pSS) quantitative systems pharmacology (QSP) model linking mechanistic pathways to clinical scores.

Presented by Servier and Rosa at the PAGE 2023


Rebecca Baillie, Jared Cui, Krishnakant Dasika, Hans-Christoph Schneider, Panteleimon Mavroudis, Laura Sargentini, Britta Wagenhuber, Katherine Kudrycki, Mike Reed

Incorporating complex drug PK with multiple binding targets into a QSP model to predict combined PD effects.

Presented by Sanofi and Rosa at the PAGE 2023

"We enable our clients to learn things that would be impractical or impossible to learn from empirical studies alone."
—Mike Reed, PhD, Chief Scientist, PhysioPD
Learn more about PhysioPD